ロード中...
Circulating Fibroblast Growth Factor 21 (Fgf21) as Diagnostic and Prognostic Biomarker in Renal Cancer
BACKGROUND: The finding of new biomarkers is needed to have a better sub-classification of primary renal tumors (RCC) as well as more reliable predictors of outcome and therapy response. In this study, we evaluated the role of circulating FGF21, an endocrine factor, as a diagnostic and prognostic bi...
保存先:
| 出版年: | J Mol Biomark Diagn |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4922529/ https://ncbi.nlm.nih.gov/pubmed/27358750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2155-9929.S2-015 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|